Daniel Powell

Daniel Powell has over 25 years of experience delivering technical solutions across multiple industries. In 2006, Mr. Powell found his true passion in medical devices, specifically neurostimulation, and has since launched multiple products in the space, including Deep Brain Stimulation for movement disorders and Vagus Nerve Stimulation for Epilepsy. Mr. Powell co-founded and serves as CEO of Spark Biomedical, the developer of the FDA-cleared Sparrow Ascent; a novel, wearable neurostimulation solution to address opioid withdrawal and addiction. Under Mr. Powell's leadership, Spark continues to advance the science of wearable neurostimulation and is developing a novel new solution to improve hemostasis, harnessing the power of the nervous system to cause platelets to form quicker, stronger clots - turning potentially unsurvivable wounds, survivable. As one General said, turning the "Golden Hour" into the "Golden 6 hours".